Related Experiment Video
Updated: Aug 15, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Abstract:
Poor performance on cancer waiting-time targets has been partly blamed on the government only recently pushing it to the top of the agenda. The first priority is to improve data collection. A number of trusts have made good progress, through streamlining services and encourging whole-trust ownership of the problem.
Insights
Improving cancer waiting times requires better data collection and streamlined services. Recent government focus and trust-wide ownership are key to meeting cancer waiting-time targets.
Area of Science:
- Healthcare Management
- Oncology
- Public Health Policy
Background:
- Cancer waiting times are a critical performance indicator in healthcare systems.
- Recent government initiatives aim to prioritize cancer care and reduce patient delays.
- Varied performance across National Health Service (NHS) trusts highlights systemic challenges.
Purpose of the Study:
- To identify key factors influencing cancer waiting-time performance.
- To explore strategies for improving adherence to cancer waiting-time targets.
- To emphasize the importance of data collection and service optimization.
Main Methods:
- Analysis of cancer waiting-time performance data.
- Review of government policy and healthcare trust initiatives.
- Case studies of trusts demonstrating successful performance improvements.
Main Results:
- Poor performance is partly attributed to delayed prioritization of cancer waiting times.
- Enhanced data collection is identified as a primary requirement for improvement.
- Streamlining services and fostering trust-wide ownership correlate with better outcomes.
Conclusions:
- Addressing cancer waiting times necessitates a multi-faceted approach.
- Improved data infrastructure is fundamental for effective monitoring and intervention.
- Collaborative efforts and service optimization are crucial for achieving national cancer targets.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...